Muken Ross sold $2K of SOPH
Muken Ross (President) sold 422 shares of SOPHiA GENETICS SA (SOPH) at $5.38 on 2026-06-22 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
This provides a fresh, primary-source datapoint on insider activity but does not include new fundamentals (guidance, trials, deals) that would materially reset valuation expectations.
Market read
Traders may note the sale for sentiment/positioning, but the 10b5-1 structure and modest size limit tradable impact.
What to watch
The dollar amount is small relative to typical market moves, and the plan is pre-arranged, so the signal-to-noise is low.
Background
The article is an SEC Form 4 insider transaction disclosure for SOPHiA GENETICS (SOPH).
Ticker impact
SEC Form 4 shows SOPHiA GENETICS insider Muken Ross sold 422 shares at $5.3803 on 2026-06-22 under a 10b5-1 plan.
Low near-term impact; any reaction is likely muted unless paired with other disclosures.
The filing is a disclosed open-market sale by an officer with a pre-arranged 10b5-1 plan, which typically reduces interpretive weight.
Market effects
No clear sector read-through from a single small 10b5-1 sale.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can coincide with internal caution; traders may still watch for follow-on sales or other filings.
Key entities
- issuerSOPHiA GENETICS SA
Subject of the Form 4 insider transaction disclosure.
- insiderMuken Ross
President and reporting insider who sold shares under a 10b5-1 plan.
